M. Diez et al., Time-dependency of the prognostic effect of carcinoembryonic antigen and p53 protein in colorectal adenocarcinoma, CANCER, 88(1), 2000, pp. 35-41
BACKGROUND, This study examined the prognostic information regarding the ri
sk of postoperative tumor recurrence obtained by simultaneous determination
of preoperative serum carcinoembryonic antigen (CEA) and immunohistochemic
al expression of p53 protein in tumor tissue from patients with colorectal
carcinoma.
METHODS. A retrospective study of 174 patients (AJCC/UICC Stages I, II and
III) was conducted. Serum CEA levels were determined by an enzyme-linked im
munoadsorbent assay. Immunohistochemical expression of nuclear p53 protein
was assessed in formalin fixed, paraffin embedded archival tumor tissue. Th
e results of both factors were categorized by clinical and histopathologic
variables. The relative prognostic significance of all factors with regard
to disease free survival was assessed by Cox proportional hazards regressio
n analysis. The stability of the predictive value of both markers was asses
sed: 1) by splitting the follow-up into three intervals and performing sepa
rate analyses for each period and 2) graphically by plotting the correspond
ing cumulative hazards ratio along the follow-up.
RESULTS. Eighty-two (47%) tumors manifested overexpression of p53 protein a
nd 60 tumors (34.4%) exhibited elevated serum CEA levels (cutoff value of 5
ng/mL). p53 positive immunostaing and elevated CEA levels were associated
with low cumulative disease free survival at 60 months' of follow-up, and p
roved to have independent prognostic significance. Analysis performed in di
fferent time periods of follow-up showed that the prognostic effect of both
markers was not stable over time. The predictive significance of CEA and p
53 changed along the study periods. An elevated preoperative CEA level was
an indicator of a high risk of recurrence only during the first 2 years aft
er surgery (hazards ratio, 3.26; 95% confidence interval [95% CI], 1.6-6.42
). The presence of p53 immunoreactivity in the primary tumor was an indicat
or of a high risk of recurrence only after the first year of follow-up (haz
ards ratio, 4.02; 95% CI, 1.68-9.6).
CONCLUSIONS. The serum CEA level and expression of p53 protein provide comp
lementary prognostic information. Time-dependency of the prognostic influen
ce of both parameters should be taken into consideration when establishing
postoperative predictive estimations. Cancer 2000;88:35-41, (C) 2000 Americ
an Cancer Society.